Read + Share
Nierengarten MB. Targeting metabolic abnormality for advanced prostate cancer: The prodrug
Platin-L effectively targets the metabolic abnormality needed to make this cancer
sensitive to cisplatin. Cancer 2023;129:3516.
PMID: 37898827
|
 |
|
Nierengarten MB. Targeting metabolic abnormality for advanced prostate cancer: The prodrug
Platin-L effectively targets the metabolic abnormality needed to make this cancer
sensitive to cisplatin. Cancer 2023;129:3516.
PMID: 37898827
|
|
|
|